Innoture Medical Technology
Innoture has assembled a team of commercial and academic expertise to deliver next generation transdermal devices for use in multiple applications within drug delivery and diagnostics. It holds worldwide patents enabling the company to adopt a unique position in the manufacture, development and commercialisation of microneedle technologies. Microneedles have been clinically proven to effectively transport large molecule drugs or active pharmaceutical ingredients (APIs) and vaccines via, but not restricted to, transdermal delivery. Whist microneedle research is extensive. Innoture is confident that its manufacturing solution is significantly superior and eminently more flexible in adaptations of delivery modalities. Innoture’s patented microneedles offer extreme flexibility compared with standard and traditional microneedle technologies and processes, allowing layering of compounds, flexibility of substrates and dynamic mass manufacture that is cost effective.